Ernst Schonbrunn
Affiliations: | University of Kansas, Lawrence, KS, United States |
Area:
BiochemistryGoogle:
"Ernst Schonbrunn"Mean distance: (not calculated yet)
Children
Sign in to add traineeMelanie A. Priestman | grad student | 2005 | University of Kansas |
Todd A. Funke | grad student | 2008 | University of Kansas |
Huijong Han | grad student | 2008 | University of Kansas |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Morozova A, Chan SC, Bayle S, et al. (2023) Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties. European Journal of Medicinal Chemistry. 266: 116101 |
Faber EB, Sun L, Tang J, et al. (2023) Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding. Nature Communications. 14: 3213 |
Lee JC, Hong KH, Becker A, et al. (2021) Tetrahydroindazole inhibitors of CDK2/cyclin complexes. European Journal of Medicinal Chemistry. 214: 113232 |
Hanna CB, Mudaliar D, John K, et al. (2020) Development of WEE2 kinase inhibitors as novel non-hormonal female contraceptives that target meiosis†. Biology of Reproduction |
Ycas PD, Zahid H, Chan A, et al. (2020) New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development. Organic & Biomolecular Chemistry |
Li Q, Karim RM, Cheng M, et al. (2020) Inhibition of p53 DNA binding by a small molecule protects mice from radiation toxicity. Oncogene |
Huang Q, Chen L, Schonbrunn E, et al. (2020) MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling. The Embo Journal. e104410 |
Olson N, Kroc S, Johnson J, et al. (2020) NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex. Biochemistry |
Durbin AD, Wimalasena V, Zimmerman MW, et al. (2020) Abstract PR11: EP300 controls the oncogenic enhancer landscape of high-risk neuroblastoma Cancer Research. 80 |
Liu X, Huang Q, Chen L, et al. (2019) Tumor-derived CK1α mutations enhance MDMX inhibition of p53. Oncogene |